Total Payments
$1,513
2024 Payments
$18.65
Companies
23
Transactions
85
Medicare Patients
1,993
Medicare Billing
$83,801
Payment Breakdown by Category
Food & Beverage$1,413 (93.4%)
Education$99.99 (6.6%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,413 | 84 | 93.4% |
| Education | $99.99 | 1 | 6.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AbbVie Inc. | $295.29 | 20 | $0 (2023) |
| Novo Nordisk Inc | $191.83 | 12 | $0 (2022) |
| Biohaven Pharmaceuticals, Inc. | $144.97 | 3 | $0 (2021) |
| GlaxoSmithKline, LLC. | $110.40 | 7 | $0 (2024) |
| Lilly USA, LLC | $104.09 | 7 | $0 (2023) |
| Astellas Pharma US Inc | $99.99 | 1 | $0 (2022) |
| SANOFI-AVENTIS U.S. LLC | $80.60 | 5 | $0 (2022) |
| PFIZER INC. | $79.70 | 5 | $0 (2022) |
| Amgen Inc. | $71.60 | 5 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $54.84 | 4 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $18.65 | 1 | GlaxoSmithKline, LLC. ($18.65) |
| 2023 | $62.17 | 3 | AbbVie Inc. ($43.25) |
| 2022 | $524.97 | 29 | ABBVIE INC. ($117.03) |
| 2021 | $700.14 | 39 | Biohaven Pharmaceuticals, Inc. ($144.97) |
| 2020 | $185.74 | 12 | SANOFI-AVENTIS U.S. LLC ($52.22) |
| 2017 | $21.31 | 1 | ViiV Healthcare Company ($21.31) |
All Payment Transactions
85 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/24/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $18.65 | General |
| Category: VACCINES | ||||||
| 01/27/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.92 | General |
| Category: Diabetes | ||||||
| 01/18/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.90 | General |
| Category: NEUROSCIENCE | ||||||
| 01/05/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: NEUROSCIENCE | ||||||
| 11/19/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: NEUROSCIENCE | ||||||
| 11/02/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: Cardio-renal | ||||||
| 10/20/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: Diabetes | ||||||
| 10/12/2022 | Mylan Specialty L.P. | Yupelri (Drug) | Food and Beverage | In-kind items and services | $15.30 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 10/04/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: NEUROSCIENCE | ||||||
| 09/19/2022 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), BOOSTRIX | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: VACCINES | ||||||
| 08/31/2022 | Astellas Pharma US Inc | — | Education | In-kind items and services | $99.99 | General |
| 08/31/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.07 | General |
| Category: Diabetes | ||||||
| 08/12/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $10.18 | General |
| Category: NEUROSCIENCE | ||||||
| 08/09/2022 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $12.87 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 07/05/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $28.96 | General |
| Category: Cardio-renal | ||||||
| 05/19/2022 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: Inflammation | ||||||
| 05/03/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $15.54 | General |
| Category: NEUROSCIENCE | ||||||
| 04/26/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.08 | General |
| Category: NEUROSCIENCE | ||||||
| 04/19/2022 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $13.39 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/14/2022 | PFIZER INC. | PREVNAR 20 (Biological) | Food and Beverage | In-kind items and services | $17.84 | General |
| Category: VACCINES | ||||||
| 04/12/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $19.06 | General |
| Category: RESPIRATORY | ||||||
| 04/11/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $20.48 | General |
| Category: Diabetes | ||||||
| 03/24/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.80 | General |
| Category: Diabetes | ||||||
| 03/10/2022 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $13.60 | General |
| Category: VACCINES | ||||||
| 03/08/2022 | PFIZER INC. | PREMARIN (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: WOMENS HEALTH | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 9 | 602 | 720 | $69,594 | $33,212 |
| 2021 | 17 | 780 | 930 | $71,592 | $29,265 |
| 2020 | 13 | 611 | 674 | $60,218 | $21,324 |
Total Patients
1,993
Total Services
2,324
Medicare Billing
$83,801
Procedure Codes
39
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 118 | 118 | $24,938 | $14,421 | 57.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 92 | 133 | $24,833 | $11,283 | 45.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 23 | 23 | $7,130 | $2,512 | 35.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 27 | 32 | $4,368 | $1,581 | 36.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 20 | 20 | $1,485 | $1,338 | 90.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 24 | 24 | $768.00 | $651.60 | 84.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 155 | 216 | $3,456 | $633.15 | 18.3% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 18 | 18 | $576.00 | $491.97 | 85.4% |
| 81003 | Automated urinalysis test | Office | 2022 | 125 | 136 | $2,040 | $301.79 | 14.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 69 | 102 | $18,666 | $8,305 | 44.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 59 | 59 | $12,272 | $7,353 | 59.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 42 | 48 | $6,528 | $3,194 | 48.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 23 | 23 | $7,130 | $2,339 | 32.8% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2021 | 12 | 12 | $1,740 | $1,505 | 86.5% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2021 | 70 | 79 | $4,266 | $1,327 | 31.1% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 16 | 16 | $1,090 | $1,029 | 94.4% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2021 | 57 | 63 | $4,536 | $843.57 | 18.6% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2021 | 70 | 79 | $4,266 | $834.24 | 19.6% |
| 85027 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2021 | 74 | 86 | $2,752 | $556.42 | 20.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 98 | 139 | $2,224 | $417.00 | 18.8% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 26 | 35 | $1,820 | $339.85 | 18.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 20 | 20 | $640.00 | $314.98 | 49.2% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2021 | 25 | 30 | $780.00 | $270.60 | 34.7% |
| 81003 | Automated urinalysis test | Office | 2021 | 86 | 102 | $1,530 | $229.50 | 15.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2021 | 13 | 13 | $416.00 | $204.73 | 49.2% |
About Dr. Laura Riley, M.D
Dr. Laura Riley, M.D is a Internal Medicine healthcare provider based in Hillsborough, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/22/2016. The National Provider Identifier (NPI) number assigned to this provider is 1659725083.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Laura Riley, M.D has received a total of $1,513 in payments from pharmaceutical and medical device companies, with $18.65 received in 2024. These payments were reported across 85 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($1,413).
As a Medicare-enrolled provider, Riley has provided services to 1,993 Medicare beneficiaries, totaling 2,324 services with total Medicare billing of $83,801. Data is available for 3 years (2020–2022), covering 39 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Student in an Organized Health Care Education/Training Program, Internal Medicine
- Location Hillsborough, NJ
- Active Since 04/22/2016
- Last Updated 10/12/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1659725083
Products in Payments
- VRAYLAR (Drug) $198.51
- NURTEC ODT (Drug) $144.97
- Ozempic (Drug) $103.61
- SOLIQUA 100/33 (Biological) $80.60
- TRULICITY (Drug) $70.10
- Rybelsus (Drug) $68.80
- SHINGRIX (Biological) $63.92
- FARXIGA (Drug) $54.84
- UBRELVY (Drug) $46.60
- Kerendia (Drug) $44.96
- Aimovig (Biological) $42.45
- QULIPTA (Drug) $42.07
- TRINTELLIX (Drug) $34.75
- MOUNJARO (Drug) $33.99
- ELIQUIS (Drug) $30.86
- Absorica LD (Drug) $28.57
- TRELEGY ELLIPTA (Drug) $26.84
- SUNOSI (Drug) $21.43
- ANORO ELLIPTA (Drug) $19.64
- RYBELSUS (Drug) $19.42
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Hillsborough
Bhavi Patel, M.d, M.D
Internal Medicine — Payments: $5,647
Internal Medicine $5,647
Nazar Raoof, Md, MD
Internal Medicine — Payments: $4,703
Internal Medicine $4,703
Dr. Lin Chou, M.d, M.D
Internal Medicine — Payments: $2,598
Internal Medicine $2,598
Dr. Natalia Raoof, M.d, M.D
Internal Medicine — Payments: $1,579
Internal Medicine $1,579
Dr. Rosario Manalo, Md, MD
Internal Medicine — Payments: $1,368
Internal Medicine $1,368
Ranjana Thakur, Md, MD
Internal Medicine — Payments: $387.04
Internal Medicine $387.04